Our website uses cookies so that we can provide you a better online experience and service;
by continuing, you agree to our use of cookies in line with our Privacy Statement
Open submenu
19 Nov 2013 - 15:00

DuPont Nutrition & Health Obtains U.S. FDA GRAS Status for Probiotics

DuPont Nutrition & Health has attained official confirmation from the U.S. Food & Drug Administration (FDA) that the probiotic strains in its Bifidobacterium lactis range are recognized as safe and suitable for use in all food products and dietary supplements.

FDA had previously granted the Bifidobacterium lactic strains full GRAS status for use in dairy applications. With this notification, FDA extends the status to food categories such as juice, dry beverages, confectionery and bakery products and the dietary supplement market, where probiotics are widely used.
DuPont previously had self-affirmed GRAS status for the use of its Bifidobacterium lactis strains in this range of additional applications.

Science-Backed Safety
“Along with proving the health benefits of the strains in our Bifidobacterium lactis range, we are committed to safety,” said Scott Bush, vice president of marketing, DuPont Nutrition & Health.
“GRAS affirmation by FDA confirms that the science behind these strains is sufficient to guarantee their safety in foods and supplements. This greatly expands the application options available to our customers,” he added.

Fast and Flexible Nutritional Gains
Strains in the B. lactis range include Bifidobacterium lactis HN019™, marketed as HOWARU® Bifido. Effective, stable and one of the most clinically studied probiotic strains available today, these health-enhancing bacteria swiftly and simply raise the nutritional profile of food brands.

Bifidobacterium lactis Bi-07™ and Bifidobacterium lactis Bl-04™ are part of the FloraFIT® custom probiotics range which offers manufacturers supreme flexibility with the widest selection of strains in the industry for the formulation of dietary supplements and nutritionals.

New Studies in the Pipeline
DuPont invests significant resources in scientific research to investigate the potential of probiotics to benefit health.

“The results of our human clinical trials document the immune and digestive health benefits of probiotics in infants, children and healthy adults. We’ve just had a study published in Clinical Nutrition, and many more are in the pipeline,” Bush stated.

These findings are backed by numerous external studies. Among the most recent is the Human Microbiome Project, initiated by the U.S. National Institutes of Health. This confirms that the strains in HOWARU® and FloraFit® probiotics are natural, beneficial components of the gastrointestinal tract.


DuPont™ Danisco® is the brand for a range of ingredients that help provide enhanced bioprotection, an improved nutritional profile, and better taste and texture with greater cost efficiency and lower environmental impact, meeting the needs of manufacturers of food and beverages, dietary supplements and pet food. Through the work of the global network of food scientists and technologists in DuPont, the Danisco® range is supported by a uniquely broad spectrum of know-how across applications and processing. For more information on DuPont™ Danisco®, go to: www.danisco.com.

DuPont Nutrition & Health addresses the world’s challenges in food by offering a wide range of sustainable, bio-based ingredients and advanced microbial diagnostic solutions to provide safer, healthier and more nutritious food.  Through close collaboration with customers, DuPont combines knowledge and experience with a passion for innovation to deliver unparalleled customer value to the marketplace.

DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802.  The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment.  For additional information about DuPont and its commitment to inclusive innovation, please visit www.dupont.com.

The DuPont Oval Logo, DuPont™, Danisco®, HOWARU®, FloraFIT®, Bifidobacterium lactis HN019™, Bifidobacterium lactis Bi-07™ and Bifidobacterium lactis Bl-04™ are registered trademarks or trademarks of DuPont or its affiliates.

Sarah Jane Jumppanen
Sarah Jane Jumppanen
Communications Director
+44 1737 227720
Reigate, United Kingdom